secwatch.observer — SEC 8-K summary
======================================

Issuer:     RECURSION PHARMACEUTICALS, INC. (RXRX)
CIK:        0001601830
Form:       8-K
Filed at:   2024-12-03T23:59:59+00:00
Accession:  0001601830-24-000232
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Recursion CFO Ben Taylor gets $5M equity grant, enhanced vesting on Exscientia awards
--------------------------------------------------------------------------------

- Ben Taylor (CFO) enters employment letter with Exscientia AI Ltd, base salary £400K/year.
- Annual cash bonus target 25% of base salary; equity bonus target also 25%.
- New equity grant of $5M (50% RSUs, 50% options) vesting over 4 years, subject to board approval.
- Pre-existing Exscientia awards (Exchanged Awards) fully vest if terminated w/o cause or resign for good reason within 12 months of Nov 20, 2024 closing.
- Employment requires 3 months' notice/pay in lieu; garden leave may offset severance plan benefits.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1601830/000160183024000232/0001601830-24-000232-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1601830/000160183024000232/rxrx-20241202.htm
  HTML page:      https://secwatch.observer/filing/0001601830-24-000232

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer